Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue

Over the past two decades, cancer treatment has benefited from having a significant increase in the number of targeted drugs approved by the United States Food and Drug Administration. With the introduction of targeted therapy, a great shift towards a new era has taken place that is characterized by...

Descripción completa

Detalles Bibliográficos
Autores principales: Loria, Rossella, Vici, Patrizia, Di Lisa, Francesca Sofia, Soddu, Silvia, Maugeri-Saccà, Marcello, Bon, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259985/
https://www.ncbi.nlm.nih.gov/pubmed/35814399
http://dx.doi.org/10.3389/fonc.2022.877380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259985/
https://www.ncbi.nlm.nih.gov/pubmed/35814399
http://dx.doi.org/10.3389/fonc.2022.877380

Ejemplares similares